mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.09 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.09 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.079 |
0.09 |